VIR BIOTECHNOLOGY, INC.

Commercial-stage immunology company

499 Illinois Street Ste 500 San Francisco CA 94158, San Francisco, CA  ·  SASHA DAMOUNI

Filings
11
Clients
1
Total Income
Years Active
2021–2023

Filings

Year Client Period Income Expenses Doc
2023 VIR BIOTECHNOLOGY, INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Termination
$70,000
2023 VIR BIOTECHNOLOGY, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$140,000
2023 VIR BIOTECHNOLOGY, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$160,000
2023 VIR BIOTECHNOLOGY, INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$140,000
2022 VIR BIOTECHNOLOGY, INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$140,000
2022 VIR BIOTECHNOLOGY, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$150,000
2022 VIR BIOTECHNOLOGY, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$140,000
2022 VIR BIOTECHNOLOGY, INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$170,000
2021 VIR BIOTECHNOLOGY, INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$120,000
2021 VIR BIOTECHNOLOGY, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$170,000
Page 1 of 2  ·  11 filings Next

Clients Represented

ClientFilingsTotal Income
VIR BIOTECHNOLOGY, INC. 11

Lobbyists

NameDisclosed Prior Position
DOUGLAS STOSS Cong. John Shadegg - Legislative Assistant, Subcommittee Staff Director, Chief of Staff, Policy Director; Centers for M…